834
Participants
Start Date
December 5, 2020
Primary Completion Date
September 3, 2021
Study Completion Date
October 8, 2021
CyclASol topical ocular, eye drops
Cyclosporine A solution in vehicle
Vehicle topical ocular, eye drops
Vehicle
CYS-004 Investigational Site, Cranberry Township
CYS-004 Investigational Site, Lynchburg
CYS-004 Investigational Site, Raleigh
CYS-004 Investigational Site, Shelby
CYS-004 Investigational Site, Fort Lauderdale
CYS-004 Investigational Site, Smyrna
CYS-004 Investigational Site, Memphis
CYS-004 Investigational site, Louisville
CYS-004 Investigational Site, Indianapolis
CYS-004 Investigational Site, Carmel
CYS-004 Investigational Site, Medina
CYS-004 Investigational Site, Fargo
CYS-004 Investigational Site, Chicago
CYS-004 Investigational Site, Kansas City
CYS-004 Investigation Site, Kansas City
CYS-004 Investigational Site, Colorado Springs
CYS-004 Investigational Site, Layton
CYS-004 Investigational site, Ogden
CYS-004 Investigational Site, Phoenix
CYS-004 Investigational Site, Henderson
CYS-004 Investigational Site, Los Angeles
CYS-004 Investigational Site, Newport Beach
CYS-004 Investigational Site, Santa Ana
CYS-004 Investigational Site, Seattle
CYS-004 Investigational Site, Andover
CYS-004 Investigational Site, Raynham
CYS-004 Investigational Site, Warwick
Lead Sponsor
Novaliq GmbH
INDUSTRY